Lucira Health Inc
NASDAQ:LHDX
Relative Value
There is not enough data to reliably calculate the relative value of LHDX.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
LHDX Competitors Multiples
Lucira Health Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
L
|
Lucira Health Inc
NASDAQ:LHDX
|
1.4m USD | 0 | -0 | 0.1 | 0.1 | |
US |
Abbott Laboratories
NYSE:ABT
|
196.8B USD | 4.9 | 34.4 | 20.4 | 30.2 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
141B USD | 19.8 | 78.4 | 60.7 | 76.2 | ||
US |
Stryker Corp
NYSE:SYK
|
136.3B USD | 6.7 | 43.1 | 26.8 | 33.1 | ||
IE |
Medtronic PLC
NYSE:MDT
|
115.6B USD | 3.6 | 27.5 | 14.5 | 20.5 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
100.6B USD | 7.1 | 64.1 | 29.9 | 44.6 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
71.2B USD | 3.7 | 58.4 | 19.4 | 41 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
62.9B EUR | 2.9 | 41.4 | 19.7 | 33.2 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
57.2B USD | 9.5 | 40.8 | 29.6 | 32 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
53.8B USD | 14.8 | 99.3 | 66.9 | 87.1 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
337.8B CNY | 9.8 | 29.8 | 25.8 | 25.8 |